Sage Therapeutics, Inc. (NASDAQ:SAGE) Q3 2022 Earnings Call Transcript November 8, 2022
Sage Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-2.31 EPS, expectations were $-2.21.
Operator: Good morning. Welcome to the Sage Therapeutics’ Third Quarter 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section of Sage’s website at sagerx.com. This call is the property of...
